Call Now

Recombinant Protein to Homo sapiens (Human) Cyclin Dependent Kinase Inhibitor 3 (CDKN3)

CDI1; CIP2; KAP1; CDK2-Associated Dual Specificity Phosphatase; Kinase Associated Phosphatase; Cyclin-dependent kinase interactor 1; Cyclin-dependent kinase-interacting 2

DescriptionCyclin Dependent Kinase Inhibitor 3 (CDKN3)
Description Cyclin Dependent Kinase Inhibitor 3 (CDKN3)
Catalog NumberU480Hu01
Organism SpeciesHomo sapiens (Human)
SourceProkaryotic expression
Expression SystemE. coli
Endotoxin Level <1.0 EU per 1 µg (determined by the LAL method)
Subcellular Localizationn/a
Predicted Molecular Mass53.8kDa
Accurate Molecular Massn/a
Residues & TagsMet1~Arg212 with N-terminal His and GST Tag
Buffer Formulation 20 mM Tris, 150 mM NaCl, pH 8.0, 5% Trehalose and Proclin 300.
Form Supplied Lyophilized powder
Purity Purity was assessed by SDS-PAGE (≥98%) and by HPLC.
SDS-PAGE SDS-PAGE image for Cyclin Dependent Kinase Inhibitor 3 (CDKN3)
Isoelectric Pointn/a
Applications Positive Control; Immunogen; SDS-PAGE; WB.
Storage Instruction We recommend a quick spin followed by reconstitution in water to a concentration of 0.1–1.0 mg/mL. This solution can then be diluted into other aqueous buffers and stored at 4°C for 1 week or at -20°C for future use.
Stability The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation testing at 37°C for 48 hours. No obvious degradation or precipitation was observed under the stated test conditions. The loss rate is less than 5% within the expiration date under appropriate storage conditions.
Notes For in vitro laboratory use only. Not for clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.